Page 2 - மாசசூசெட்ஸ் உயிரி தொழில்நுட்பவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Massachusetts biopharma firms raised a record $5.8 billion in venture capital last year Jonathan Saltzman © David L. Ryan Kendall Square in Cambridge, epicenter of the state s robust biotechnology industry. Buoyed by the industry’s response to the COVID-19 pandemic, Massachusetts drug makers raised a record-breaking $5.8 billion in venture capital last year, nearly double the sum of 2019 and surpassing the previous high of $4.8 billion in 2018, according to a new report by a trade group. Popular Searches As biopharma firms had three vaccines cleared for use in the US since the coronavirus emerged in December 2019 ― including one from Cambridge-based Moderna ― investors seemed eager to fund promising startups, said the report by the Massachusetts Biotechnology Council.

United kingdomUnited statesKendalle burlin oconnellKendall squareMassachusetts biotechnology councilCambridge based modernaMassachusetts biotechnologyKendalle burlino connellஒன்றுபட்டது கிஂக்டம்ஒன்றுபட்டது மாநிலங்களில்கெஂடெல் சதுரம்மாசசூசெட்ஸ் உயிரி தொழில்நுட்பவியல் சபைகேம்பிரிட்ஜ் அடிப்படையிலானது மாடர்னாமாசசூசெட்ஸ் உயிரி தொழில்நுட்பவியல்